- Novel myeloid regulators of rheumatic diseases(2017)
Auteurs: Katelijne De Wilde
- A20 inhibition of STAT1 expression in myeloid cells : a novel endogenous regulatory mechanism preventing development of enthesitis(2017)
Auteurs: Katelijne De Wilde, Arne Martens, Michael Drennan, Julie Coudenys, Eveline Verheugen, Fien Windels, Leen Catrysse, Rik Lories, Dennis McGonagle, Rudi Beyaert, et al.
Pagina's: 585 - 592
- Assessment of sensitivity to change of the European Scleroderma Study Group activity index(2016)
Auteurs: Karin Melsens, Filip De Keyser, Saskia Decuman, Guy Brusselle, Michel De Pauw, Ellen Deschepper, Katelijne De Wilde, Dirk Elewaut, YVES PIETTE, Els Vandecasteele, et al.
Pagina's: 148 - 151
- Tofacitinib inhibits inflammation and new bone formation in murine spondyloarthritis but does not adversely inhibit normal human MSC function(2015)
Volume: 67
Auteurs: Rik Lories, Katelijne De Wilde, Kerri Heritage, Richard Cuthbert, Elena Jones, Karlijn Debusschere, Dennis McGonagle, Dirk Elewaut
Aantal pagina's: 1
- Integrating the pathogenesis of spondyloarthritis: gut and joint united?(2015)
Auteurs: Katelijne De Wilde, Karlijn Debusschere, Sam Beeckman
Pagina's: 189 - 196
- Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development(2014)
Auteurs: Katelijne De Wilde, Julie Coudenys, Dieter Deforce, Filip De Keyser
Pagina's: 418 - 427
- The thymic microenvironment differentially regulates development and trafficking of invariant NKT cell sublineages(2014)
Auteurs: Michael Drennan, Katelijne De Wilde, Susan M Schlenner, Carl Ware, Sergei Nedospasov, Hans-Reimer Rodewald
Pagina's: 5960 - 5972